Objective: To assess the efficacy, safety and tolerability of moxifloxacin, an 8-methoxy fluoroquinolone, in patients with respiratory tract infections (RTIs) treated in general practice in Germany.

Aptargroup Inc. $144.70-11.75-7.51% ...

Aurobindo Pharma Ltd.'s third-quarter profit decreased, missing analysts' estimates. The Hyderabad-based bulk and generic drug maker's net profit fell 9.7% year-on-year to Rs 846 crore in the quarter ...

Each day, BD+C's editors assemble the latest breaking industry news, hottest trends, and most relevant research, delivered to your inbox.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Michael K. Jensen, B.S.Pharm., M.S., is Clinical Associate Professor of Pharmacy Practice, College of Pharmacy, University of Utah, Salt Lake City, and Clinical ...

Bonus Mar 07, 2000 Apr 01, 2000 Feb 22, 2000 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Oct 26, 1998 Nov 19, 1998 Oct 08, 1998 Bonus Ratio: 1 share(s) for every 1 shares held Aurobindo ...

Aurobindo Pharma on Thursday reported a 10 per cent year-on-year (Y-o-Y) drop in consolidated profit after tax (PAT) for the December quarter (Q3 FY25) to Rs 845.56 crore, down from Rs 939.97 crore ...

India’s electric car market surged by 20% in 2024, with notable growth from JSW MG Motor selling 21,484 EVs, driven by the Windsor SUV. Tata Motors saw its market share dip to 38%, while ...

Generic drugmaker Aurobindo Pharma has received order under the Central Goods and Services Tax Act, 2017, asking it to pay GST, interest and a penalty of more than ₹155 crore. Additional ...